360 related articles for article (PubMed ID: 28872030)
1. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
Agustí A; Celli B; Faner R
Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
Woodruff PG; Agusti A; Roche N; Singh D; Martinez FJ
Lancet; 2015 May; 385(9979):1789-1798. PubMed ID: 25943943
[TBL] [Abstract][Full Text] [Related]
3. [Developing Biomarkers in Precision Medicine for Asthma and COPD].
Hirai K
Yakugaku Zasshi; 2023; 143(3):249-255. PubMed ID: 36858558
[TBL] [Abstract][Full Text] [Related]
4. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
[TBL] [Abstract][Full Text] [Related]
5. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
Agusti A; Sobradillo P; Celli B
Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
[TBL] [Abstract][Full Text] [Related]
6. [From COPD definitions to COPD phenotypes].
Burgel PR
Presse Med; 2014 Dec; 43(12 Pt 1):1337-43. PubMed ID: 25448122
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine and chronic obstructive pulmonary disease.
Wouters EF; Wouters BB; Augustin IM; Franssen FM
Curr Opin Pulm Med; 2017 May; 23(3):241-246. PubMed ID: 28257315
[TBL] [Abstract][Full Text] [Related]
8. Targeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers.
Garudadri S; Woodruff PG
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S234-S238. PubMed ID: 30758998
[TBL] [Abstract][Full Text] [Related]
9. COPD: To Be or Not to Be, That is the Question.
Polverino F; Sam A; Guerra S
Am J Med; 2019 Nov; 132(11):1271-1278. PubMed ID: 31152719
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in COPD: where are we and where do we need to go?
Sidhaye VK; Nishida K; Martinez FJ
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30068688
[TBL] [Abstract][Full Text] [Related]
11. How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs.
Burkes RM; Panos RJ; Borchers MT
Curr Opin Pulm Med; 2021 Mar; 27(2):120-124. PubMed ID: 33394748
[TBL] [Abstract][Full Text] [Related]
12. Introduction to precision medicine in COPD.
Leung JM; Obeidat M; Sadatsafavi M; Sin DD
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30679189
[TBL] [Abstract][Full Text] [Related]
13. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
[TBL] [Abstract][Full Text] [Related]
14. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
15. The Challenges of Precision Medicine in COPD.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
[TBL] [Abstract][Full Text] [Related]
16. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
Vanfleteren LE; Kocks JW; Stone IS; Breyer-Kohansal R; Greulich T; Lacedonia D; Buhl R; Fabbri LM; Pavord ID; Barnes N; Wouters EF; Agusti A
Thorax; 2014 Jan; 69(1):72-9. PubMed ID: 23794191
[TBL] [Abstract][Full Text] [Related]
17. The path to personalised medicine in COPD.
Agusti A
Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.
Brandsma CA; Van den Berge M; Hackett TL; Brusselle G; Timens W
J Pathol; 2020 Apr; 250(5):624-635. PubMed ID: 31691283
[TBL] [Abstract][Full Text] [Related]
19. Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities.
O'Neil SE; Lundbäck B; Lötvall J
J Proteomics; 2011 Dec; 75(1):192-201. PubMed ID: 22037230
[TBL] [Abstract][Full Text] [Related]
20. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
Agustí A
Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
